Acipimox (Standard), CAS 51037-30-0

Product Description: Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity[1][2][3].

Formula: N/A

References: [1]Vestergaard ET, et, al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. Br J Clin Pharmacol. 2017 Dec;83(12):2671-2677./[2]Wang-Fisher YL, et, al. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002 Aug;174(2):267-72./[3]Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand. 2001 Feb;171(2):161-7.

CAS Number: 51037-30-0

Molecular Weight: N/A

Research Area: Metabolic Disease

Target: Others

• Artikelnummer: MEXHY-B0283R-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-B0283R-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK